May 05, 2022 7:00am EDT Societal CDMO Signs Three-Year Manufacturing and Supply Agreement With InfectoPharm for Ritalin LA® in Europe
May 04, 2022 4:05pm EDT Societal CDMO to Report Financial Results for First Quarter 2022 on May 11, 2022
Apr 27, 2022 7:00am EDT Societal CDMO Secures Manufacturing and Packaging Task Order Award from National Cancer Institute (NCI)
Mar 21, 2022 7:00am EDT Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and Transformation
Feb 23, 2022 7:00am EST Recro Reports Progress Towards Launching Fill/Finish and Lyophilization Capabilities at San Diego Facility
Feb 22, 2022 4:05pm EST Recro to Report Financial Results for Fourth Quarter and Year-end 2021 on March 1, 2022
Jan 26, 2022 7:00am EST Recro Wins $1.5 Million Formulation Development and CGMP Manufacturing Contract to Support Clinical Development of Topical Treatment for Skin Cancer Prevention